Session: <i>C. difficile</i> Diagnostics (IDWeek 2012 Meeting)

Thursday, October 18, 2012: 12:30 PM-2:00 PM

Room: SDCC Poster Hall F-H

Topical Category: N. Infection Epidemiology and Prevention and P. Pediatric and Perinatal Infections

Tracks: Epidemiology and Infection Control, Pediatric ID

Presentations:

320

Increased Clostridium difficile (CD) Detection and Decreased Empiric Treatment/Ancillary Testing after switch from Toxin A/B Immunoassy to PCR for Diagnosis of CD Infection
Laurie Labuszewski, PharmD ; Urvashi Thakkar, PharmD ; Stuart Johnson, MD, FIDSA ; Paul Schreckenberger, PhD ; Jorge Parada, MD, MPH

Posters

ID Week final CD poster.pdf (544.0 kB)

321	Utility of Perirectal Swab Specimens for Diagnosis of Clostridium difficile Infection Sirisha Kundrapu, M.D. ; Venkata Sunkesula, M.D, M.S ; Lucy Jury, N.P. ; Ajay K. Sethi, PhD ; Curtis J. Donskey, MD

322	Commercial Clostridium difficile Toxin PCR Assay of Stools from Pediatric Inpatients with Diarrhea with Cytotoxicity Confirmation of Positives Jill Leibowitz, MD ; Vijaya Soma, MD ; Lorry Rubin, MD Posters IDSA 322 Leibowitz.pdf (423.5 kB)

323	Stools from Asymptomatic Pediatric Inpatients at Risk for Clostridium difficile-Associated Diarrhea Frequently Test Positive Using a Commercial PCR Assay Jill Leibowitz, MD ; Vijaya Soma, MD ; Lorry Rubin, MD Posters IDSA 323 Leibowitz.pdf (434.8 kB)

324

Regional Differences in Vancomycin-resistant enterococcus and C difficile co-Colonization Rates in Critically Ill Veterans
Linda McKinley, RN, BSN, MPH, CIC ; Mary Hagle, RN, PhD ; Helene Moriarty, RN, PhD ; Tom Short, PhD ; Nasia Safdar, MD, PhD

Posters

ID Week poster_RISC_VRE Regional Differences_Oct42012.pdf (3.9 MB)

325

Changes in Clostridium difficile Testing Practices and their Impact on Stool Rejection Policies across Multiple U.S. Laboratories
Jessica Cohen, MPH ; Duncan MacCannell, PhD ; Leigh Ann Clark, MPH ; Wendy Bamberg, MD ; Rebecca Perlmutter, MPH ; John Dunn, DVM, PhD ; Joelle Nadle, MPH ; Stacy Holzbauer, DVM ; Carol Lyons, MPH ; Erin Phipps, DVM ; Ghinwa Dumyati, MD, FSHEA ; Zintars G. Beldavs, MS ; Fernanda Lessa, MD

326	The Nose Knows Not: Poor Predictive Value of Stool Sample Odor for Detection of Clostridium difficile Krishna Rao, MD ; Daniel Berland, MD ; Carol Young, MT(ASCP) ; Seth Walk, MS, PhD ; Duane Newton, PhD Posters 9_10 KR IDWeek_2012 poster draft.pdf (1.8 MB)

327	Evaluation of a Commercial PCR Assay for Detection of Environmental Contamination with Clostridium difficile Abhishek Deshpande, M.D., Ph.D. ; Jennifer Cadnum, B.S. ; Brett Sitzlar, B.S. ; Sirisha Kundrapu, M.D. ; Curtis J. Donskey, MD Posters Abhishek.pdf (155.3 kB)

328

Severe Clostridium difficile Infection in Patients with Negative Results for tcdB by the Xpert� C. difficile assay
Jerome Leis, MD ; Wayne Gold, MD, FRCPC ; John Ng, PhD ; Zahir Hirji ; Dylan Pillai, MD, PhD ; George Broukhanski, PhD ; Paul Raggiunti ; Susy Hota, MD ; Allison McGeer, MD, FSHEA ; Susan Poutanen, MD, MPH

329	Does Empirical Clostridium difficile Infection (CDI) Therapy Result in False-Negative CDI Diagnostic Test Results? Venkata Sunkesula, M.D, M.S ; Sirisha Kundrapu, M.D. ; Curtis J. Donskey, MD

330

Prospective Evaluation of the Epidemiology of Clostridium difficile Colonization and Infection among Hematopoietic Stem Cell Transplant Recipients
Varinia Urday-Cornejo, MD ; Christopher Croswell ; Teena Chopra, MD, MPH ; Alyssa Liubakka ; Jessica Cutright, BS ; Hossein Salimnia, PhD ; Paul Lephart, PhD ; Sanjay Revankar, MD ; Pranatharthi Chandrasekar, MD ; George Alangaden, MD

Posters

CDI HSCT ID Week October 2012.pdf (840.9 kB)

331	Multilocus sequence typing analysis of 85 C. difficile strains isolated from a teaching hospital in Houston Texas, September through December 2011 Zhi-Dong Jiang ; Ravi Panchumarthi ; Kevin W. Garey, PharmD, M.S. ; Todd M. Lasco, PhD ; Jane Chen ; Herbert DuPont, MD, FIDSA

332	Clostridium difficile Whole Genome Sequencing Suggests Limited Transmission Arising From Mixed Infection David Eyre, BM, BCh ; Madeleine Cule, PhD ; David Griffiths, BSc ; Tim Peto, MB BS, DPhil ; A. Sarah Walker, PhD ; Daniel Wilson, DPhil

333

Title: Safety of Clostridium Difficile Testing Algorithm using Glutamate Dehydrogenase Antigen and Toxin Enzyme Immunoassay with Reflex PCR for Discordant Test
Cecilia Big, MD ; David Sengstock, MD, MS ; Natasha Bagdasarian, MD, MPH ; Vijayalakshmi Nagappan, MD ; Padmaja Vemuri, MD ; David Weidendorf, MD ; Rama Thyagarajan, MD

Posters

Slide1.JPG (1.2 MB)

334

Prevalence and Molecular Epidemiology of Clostridium difficile (CD) in Food and Companion Animals, Retail Meats, and Humans in Minnesota
Megan K. Shaughnessy, MD ; Tim Snider, DVM ; Rocio Sepulveda ; David Boxrud, MS ; Elizabeth Cebelinski, BS ; Stacy Holzbauer, DVM ; Kirk Smith, DVM, PhD ; Jeff Bender, DVM MS DACVPM ; Francisco Diez-Gonzalez, PhD ; James R. Johnson, MD

335	Screening for Vancomycin Resistant Enterococcus (VRE) Colonization During Clostridum difficile Testing is Not Cost Effective at a Canadian Teaching Hospital Sunil Varghese, MD, MA ; Kathryn Suh, MD, MSc, FRCPC ; Natalie Bruce, RN, BScN, CIC ; Karam Ramotar, PhD ; Virginia Roth, MD

336

Toxin A/B EIA Compared to Molecular Amplification Testing for Clostridium Difficile: Cost and Resource Utilization Analyses
Reda A. Awali, MD ; Brindha Gopala Krishnan, MD ; Harleen Kaur, MD ; Indu K. Chalana, MD ; Paula Robinson, RN ; Sanjay Revankar, MD ; Judy Moshos, BS, MT ; Paul Lephart, PhD ; Richard Fackler, BBA ; Keith Kaye, MD, MPH, FIDSA, FSHEA ; Teena Chopra, MD, MPH

Posters

Poster_EIA vs MA.pdf (899.0 kB)

337

Comparative Analysis of Two Culture Media and PCR for the Detection of Toxigenic and Non-Toxigenic C. difficile
Christopher Croswell ; Varinia Urday-Cornejo, MD ; Alyssa Liubakka ; Jessica Cutright, BS ; Hossein Salimnia, PhD ; Paul Lephart, PhD ; Teena Chopra, MD, MPH ; Pranatharthi Chandrasekar, MD ; George Alangaden, MD

Posters

IDSA CD media ID Week Poster October 2012.pdf (944.1 kB)

CME Credits:

See more of: Poster Abstract Session

<< Previous Session | Next Session >>